NZ576409A - A phosphorylated isoform of human alpha-enolase used in pancreatic ductal adenocarcinoma treatment and diagnosis - Google Patents

A phosphorylated isoform of human alpha-enolase used in pancreatic ductal adenocarcinoma treatment and diagnosis

Info

Publication number
NZ576409A
NZ576409A NZ576409A NZ57640907A NZ576409A NZ 576409 A NZ576409 A NZ 576409A NZ 576409 A NZ576409 A NZ 576409A NZ 57640907 A NZ57640907 A NZ 57640907A NZ 576409 A NZ576409 A NZ 576409A
Authority
NZ
New Zealand
Prior art keywords
pda
enolase
antibody
enoa
antibodies
Prior art date
Application number
NZ576409A
Other languages
English (en)
Inventor
Francesco Novelli
Barbara Tomaino
Paola Cappello
Original Assignee
Ribovax Biotechnologies Sa
Bioline Diagnostici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribovax Biotechnologies Sa, Bioline Diagnostici Srl filed Critical Ribovax Biotechnologies Sa
Publication of NZ576409A publication Critical patent/NZ576409A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ576409A 2006-09-29 2007-09-28 A phosphorylated isoform of human alpha-enolase used in pancreatic ductal adenocarcinoma treatment and diagnosis NZ576409A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06121552 2006-09-29
EP06126726 2006-12-20
PCT/EP2007/060305 WO2008037792A1 (en) 2006-09-29 2007-09-28 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma

Publications (1)

Publication Number Publication Date
NZ576409A true NZ576409A (en) 2012-02-24

Family

ID=38895810

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ576409A NZ576409A (en) 2006-09-29 2007-09-28 A phosphorylated isoform of human alpha-enolase used in pancreatic ductal adenocarcinoma treatment and diagnosis

Country Status (18)

Country Link
US (1) US8071721B2 (enExample)
EP (1) EP2069395B1 (enExample)
JP (1) JP2010505104A (enExample)
KR (1) KR20090094227A (enExample)
CN (1) CN101578295B (enExample)
AT (1) ATE542831T1 (enExample)
AU (1) AU2007301966B2 (enExample)
BR (1) BRPI0717282A2 (enExample)
CA (1) CA2664841A1 (enExample)
DK (1) DK2069395T3 (enExample)
EA (1) EA016731B1 (enExample)
ES (1) ES2381304T3 (enExample)
IL (2) IL197868A (enExample)
NO (1) NO20091662L (enExample)
NZ (1) NZ576409A (enExample)
PL (1) PL2069395T3 (enExample)
PT (1) PT2069395E (enExample)
WO (1) WO2008037792A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009137832A2 (en) * 2008-05-09 2009-11-12 Duke University Autoantibodies in the detection and treatment of cancer
IT1398782B1 (it) * 2009-09-11 2013-03-18 Novelli Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi.
ITTO20120523A1 (it) * 2012-06-15 2013-12-16 Natimab Therapeutics S R L Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico
EP3083697B1 (en) * 2013-12-20 2019-04-17 Development Center for Biotechnology Alpha-enolase specific antibodies and methods of uses in cancer therapy
AU2015204452A1 (en) 2014-01-13 2016-08-11 Berg Llc Enolase 1 (Eno1) compositions and uses thereof
CN115786317B (zh) * 2022-12-12 2026-03-20 江苏三联生物工程股份有限公司 重组神经元特异性烯醇化酶及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753446A (en) * 1993-04-15 1998-05-19 National Jewish Center For Immunology & Respiratory Medicine Mitogen ERK kinase kinase (MEKK) assay

Also Published As

Publication number Publication date
BRPI0717282A2 (pt) 2013-10-15
EA016731B1 (ru) 2012-07-30
AU2007301966A1 (en) 2008-04-03
ATE542831T1 (de) 2012-02-15
KR20090094227A (ko) 2009-09-04
DK2069395T3 (da) 2012-05-14
CA2664841A1 (en) 2008-04-03
IL197868A0 (en) 2011-08-01
CN101578295A (zh) 2009-11-11
EP2069395B1 (en) 2012-01-25
CN101578295B (zh) 2013-02-27
NO20091662L (no) 2009-06-29
AU2007301966B2 (en) 2013-02-21
PL2069395T3 (pl) 2012-06-29
US8071721B2 (en) 2011-12-06
JP2010505104A (ja) 2010-02-18
IL218442A0 (en) 2012-04-30
EP2069395A1 (en) 2009-06-17
WO2008037792A1 (en) 2008-04-03
EA200970332A1 (ru) 2009-10-30
IL197868A (en) 2013-03-24
PT2069395E (pt) 2012-04-27
ES2381304T3 (es) 2012-05-25
US20100028907A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
AU2007301966B2 (en) Novel antigens and antibodies associated to Pancreatic Ductal Adenocarcinoma
Zhao et al. Proteomic identification of glycosylphosphatidylinositol anchor-dependent membrane proteins elevated in breast carcinoma
Hwang et al. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma
Martelli et al. Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study
Zhang et al. Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA
Sheng et al. SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis
Frączyk et al. Properties of phosphorylated thymidylate synthase
EP3042203B1 (en) Biomarkers for cholangiocellular carcinoma (ccc)
Halkidis et al. Mechanistic insight into multiple antibody binding to ADAMTS13 in immune thrombotic thrombocytopenic purpura
CA2909474C (en) New method for monitoring cancer and/or inflammatory reaction based on relb phosphorylation
Zaragozá et al. Nitration of cathepsin D enhances its proteolytic activity during mammary gland remodelling after lactation
Thakar et al. SUMOylation of the hepatoma‐derived growth factor negatively influences its binding to chromatin
US20200057082A1 (en) Method of measuring cholesterol levels by using immunogenic method
Ye et al. Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics
DK2447719T3 (en) proteins
KR102645065B1 (ko) Brd2 특이반응 자가면역항체 암 바이오마커, 이의 검출을 위한 항원 조성물 및 이를 이용한 간암 진단법
CN102135542A (zh) 用于检测可溶性pdcd5蛋白的elisa方法和试剂盒
Sarıhan et al. Endoplazmik retikuluma lokalize edilen TurboID aracılı işaretleme ile MCF-10A ve MDA-MB-231 hücrelerine ait sekretom profillerinin belirlenmesi
Miranda et al. Heterologous expression of Homo sapiens alpha-folate receptors in E. coli by fusion with a trigger factor for enhanced solubilization
WO2011149402A2 (en) Prostate cancer biomarkers
KR20110117366A (ko) 전립선암 줄기세포 선별용 단백질성 마커
Tian et al. USP13 Regulates the Breast Tumor Proliferation and Migration through the Stabilization of PDCD4 Protein
Zhao et al. Targeted extracellular degradation of LRP8 promotes ferroptosis in cancer cells
EP3346271A1 (en) Methods and kits for detecting cancer
Ojefua Study of connexin-43 protein-protein interactions involved in glioma migration, A

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed